Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1950 1
1953 1
1954 1
1955 1
1957 1
1958 1
1959 1
1961 2
1962 3
1963 1
1964 3
1965 1
1968 2
1969 3
1970 2
1971 1
1972 3
1973 3
1974 1
1975 7
1976 8
1977 9
1978 7
1979 7
1980 5
1981 13
1982 14
1983 11
1984 10
1985 12
1986 12
1987 14
1988 13
1989 19
1990 17
1991 12
1992 17
1993 19
1994 19
1995 31
1996 26
1997 21
1998 29
1999 27
2000 18
2001 21
2002 34
2003 24
2004 32
2005 17
2006 33
2007 37
2008 46
2009 36
2010 32
2011 34
2012 37
2013 41
2014 38
2015 49
2016 46
2017 50
2018 35
2019 33
2020 41
2021 44
2022 45
2023 43
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

1,177 results

Results by year

Filters applied: . Clear all
Page 1
Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial.
Avery RK, Alain S, Alexander BD, Blumberg EA, Chemaly RF, Cordonnier C, Duarte RF, Florescu DF, Kamar N, Kumar D, Maertens J, Marty FM, Papanicolaou GA, Silveira FP, Witzke O, Wu J, Sundberg AK, Fournier M; SOLSTICE Trial Investigators. Avery RK, et al. Among authors: fournier m. Clin Infect Dis. 2022 Sep 10;75(4):690-701. doi: 10.1093/cid/ciab988. Clin Infect Dis. 2022. PMID: 34864943 Free PMC article. Clinical Trial.
Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial.
Peyrade F, Jardin F, Thieblemont C, Thyss A, Emile JF, Castaigne S, Coiffier B, Haioun C, Bologna S, Fitoussi O, Lepeu G, Fruchart C, Bordessoule D, Blanc M, Delarue R, Janvier M, Salles B, André M, Fournier M, Gaulard P, Tilly H; Groupe d'Etude des Lymphomes de l'Adulte (GELA) investigators. Peyrade F, et al. Among authors: fournier m. Lancet Oncol. 2011 May;12(5):460-8. doi: 10.1016/S1470-2045(11)70069-9. Epub 2011 Apr 7. Lancet Oncol. 2011. PMID: 21482186 Clinical Trial.
CMOS electrochemical pH localizer-imager.
Jung HS, Jung WB, Wang J, Abbott J, Horgan A, Fournier M, Hinton H, Hwang YH, Godron X, Nicol R, Park H, Ham D. Jung HS, et al. Among authors: fournier m. Sci Adv. 2022 Jul 29;8(30):eabm6815. doi: 10.1126/sciadv.abm6815. Epub 2022 Jul 27. Sci Adv. 2022. PMID: 35895813 Free PMC article.
The ICOS-ICOSL pathway tunes thymic selection.
Dong M, Chang J, Lebel MÈ, Gervais N, Fournier M, Mallet Gauthier È, Suh WK, Melichar HJ. Dong M, et al. Among authors: fournier m. Immunol Cell Biol. 2022 Mar;100(3):205-217. doi: 10.1111/imcb.12520. Epub 2022 Jan 23. Immunol Cell Biol. 2022. PMID: 34962663 Free PMC article.
Sesamoidectomy in Athletes: Outcomes From 2-Centers.
Saxena A, Fournier M, Patel P, Maffulli N. Saxena A, et al. Among authors: fournier m. J Foot Ankle Surg. 2022 Jan-Feb;61(1):139-142. doi: 10.1053/j.jfas.2021.07.008. Epub 2021 Jul 21. J Foot Ankle Surg. 2022. PMID: 34353730
An Aqueous Analog MAC Machine.
Jung WB, Jung HS, Wang J, Hinton H, Fournier M, Horgan A, Godron X, Nicol R, Ham D. Jung WB, et al. Among authors: fournier m. Adv Mater. 2023 Sep;35(37):e2205096. doi: 10.1002/adma.202205096. Epub 2022 Sep 9. Adv Mater. 2023. PMID: 35998945
SARS-CoV-2 Omicron BA.1 breakthrough infection drives late remodeling of the memory B cell repertoire in vaccinated individuals.
Sokal A, Barba-Spaeth G, Hunault L, Fernández I, Broketa M, Meola A, Fourati S, Azzaoui I, Vandenberghe A, Lagouge-Roussey P, Broutin M, Roeser A, Bouvier-Alias M, Crickx E, Languille L, Fournier M, Michel M, Godeau B, Gallien S, Melica G, Nguyen Y, Canoui-Poitrine F, Pirenne F, Megret J, Pawlotsky JM, Fillatreau S, Reynaud CA, Weill JC, Rey FA, Bruhns P, Mahévas M, Chappert P. Sokal A, et al. Among authors: fournier m. Immunity. 2023 Sep 12;56(9):2137-2151.e7. doi: 10.1016/j.immuni.2023.07.007. Epub 2023 Aug 4. Immunity. 2023. PMID: 37543032
Clostridium botulinum type C, D, C/D, and D/C: An update.
Meurens F, Carlin F, Federighi M, Filippitzi ME, Fournier M, Fravalo P, Ganière JP, Grisot L, Guillier L, Hilaire D, Kooh P, Le Bouquin-Leneveu S, Le Maréchal C, Mazuet C, Morvan H, Petit K, Vaillancourt JP, Woudstra C. Meurens F, et al. Among authors: fournier m. Front Microbiol. 2023 Jan 5;13:1099184. doi: 10.3389/fmicb.2022.1099184. eCollection 2022. Front Microbiol. 2023. PMID: 36687640 Free PMC article. Review.
Mir-21 Suppression Promotes Mouse Hepatocarcinogenesis.
Correia de Sousa M, Calo N, Sobolewski C, Gjorgjieva M, Clément S, Maeder C, Dolicka D, Fournier M, Vinet L, Montet X, Dufour JF, Humar B, Negro F, Sempoux C, Foti M. Correia de Sousa M, et al. Among authors: fournier m. Cancers (Basel). 2021 Oct 4;13(19):4983. doi: 10.3390/cancers13194983. Cancers (Basel). 2021. PMID: 34638467 Free PMC article.
1,177 results